-+ 0.00%
-+ 0.00%
-+ 0.00%

Aimwell Partners unit AimwellBio acquires Trustr IP portfolio valued at $10 million

PUBT·08/13/2026 13:00:19
Listen to the news
Aimwell Partners unit AimwellBio acquires Trustr IP portfolio valued at $10 million
  • Aimwell Partners (OTC:AIMN) disclosed an investor briefing on its acquisition of the Trustr intellectual property portfolio, valued at $10 million.
  • Assets include a U.S. patent family for systems that measure real-world behavior against personalized indicators to trigger reward or loss-aversion messaging.
  • The portfolio is positioned as a behavioral engagement layer for medication adherence, remote patient monitoring, clinical trial retention, patient-reported outcomes.
  • Inventor Chris A. Jones joined AimwellBio’s advisory board to help expand the platform through additional intellectual property and operating talent.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aimwell Partners Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 202608130900ACCESSWRNAPR_____1206929) on August 13, 2026, and is solely responsible for the information contained therein.